Is Xencor Inc (XNCR) overvalued? · rev $55.7M
Xencor Inc (XNCR) is a biotechnology company listed on US.
This page asks whether Xencor Inc (XNCR) looks expensive on cached numbers — not a short thesis.
Latest reported XNCR revenue for 2026-06-30 was $55.7M. Net income was -$150.6M. XNCR currently screens at market cap $664.0M.
XNCR currently screens at market cap $664.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next XNCR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the XNCR stock page for the full model, not this heading.
Not investment advice.